Novel Test Predicts Risk Of Invasive Breast Cancer
Scientists from University of California, San Francisco (UCSF) discovered a breakthrough method that will predict whether women with ductal carcinoma in situ (DCIS, the most common form of non-invasive breast cancer) are at risk of developing more invasive tumors in the future. The researchers found that different combinations of biomarkers measured on the initial DCIS tissue were associated with varying levels of risk of invasive cancer or DCIS.
With this new test, women with DCIS are now able to be more selective about their treatment option. While physicians will now be able to predict whether a DCIS patient treated by lumpectomy only will subsequently develop invasive cancer, DCIS, or be at very low risk of developing further tumors.
Findings were reported in the Journal of the National Cancer Institute.
May 5th, 2010 at 3:58 am
However, it is possible to reduce the chances of developing breast cancer by knowing about what puts you at breast cancer risk. For this reason, it is important to know what factors can increase or decrease breast cancer risk and how much those factors change your risk.
May 21st, 2010 at 10:18 pm
This is a huge break through and help many women at risk of breast cancer.
July 6th, 2010 at 5:18 am
This is a revolutionary event as several women with DCIS can undergo special test that wud help them in detecting the risk involved in developing nvasive tumors in the coming years.